Koers Mabwell (Shanghai) Bioscience Co., Ltd.
Aandelen
688062
CNE100005RD2
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,5 CNY | +3,19% | +2,50% | +11,65% |
Omzet 2024 * | 415 mln. 57,49 mln. 53,42 mln. | Omzet 2025 * | 1,12 mld. 155 mln. 144 mln. | Marktkapitalisatie | 14,59 mld. 2,02 mld. 1,88 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -819 mln. -113 mln. -105 mln. | Nettowinst (verlies) 2025 * | -557 mln. -77,17 mln. -71,69 mln. | EV/omzet 2024 * | 35,1 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 13 x |
K/w-verhouding 2024 * |
-17,8
x | K/w-verhouding 2025 * |
-26,2
x | Werknemers | 1.491 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 47,33% |
1 dag | +3,19% | ||
1 week | +2,50% | ||
Lopende maand | +3,19% | ||
1 maand | +8,50% | ||
3 maanden | +41,69% | ||
6 maanden | +31,29% | ||
Lopend jaar | +11,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Da Tao Liu
CEO | Chief Executive Officer | 52 | 01-07-17 |
Jin Hua
DFI | Director of Finance/CFO | 43 | 27-06-23 |
Xin Du
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-06-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bo Ling Li
BRD | Director/Board Member | 70 | 11-10-20 |
Chun Shan Tang
BRD | Director/Board Member | 55 | 01-04-19 |
Da Tao Liu
CEO | Chief Executive Officer | 52 | 01-07-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
06-05-24 | 36,5 | +3,19% | 3 207 003 |
30-04-24 | 35,37 | -0,67% | 1 324 850 |
slotkoers Shanghai S.E., 06 mei 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,65% | 1,95 mld. | |
+9,15% | 105 mld. | |
-1,08% | 104 mld. | |
+5,79% | 22,94 mld. | |
-11,55% | 22,34 mld. | |
-7,01% | 19,25 mld. | |
-37,08% | 17,08 mld. | |
-9,91% | 16,96 mld. | |
+7,55% | 14,16 mld. | |
+40,04% | 12,63 mld. |